Skip directly to Accessibility Notice

PPH
VanEck Vectors Pharmaceutical ETF

Fund Description

VanEck Vectors® Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

 
 

  • Fund Ticker

    PPH
  • Exchange

    NASDAQ
  • ETF Structure

    Physical
  • Administrator

    Van Eck Associates
  • Custodian

    State Street Bank and Trust Company
  • Index Ticker

    MVPPHTR
  • Index Rebalancing

    Quarterly

 
as of 07/23/21

  • 30-Day SEC Yield1

    1.54%
  • Total Net Assets

    $319.0M
  • Number of Holdings

    25
  • Options

    Available
  • Gross Expense Ratio2

    0.42%
  • Net Expense Ratio/TER2

    0.35%
  • Distribution Frequency

    Quarterly

Key Points

  • Highly Liquid Companies 
    Index seeks to track the most liquid companies in the industry based on market capitalization and trading volume

  • Industry Leaders
    Index methodology favors the largest companies in the industry

  • Global Scope 
    Portfolio may include both domestic and U.S. listed foreign companies, allowing for enhanced industry representation

Trading Information

  • Fund Ticker

    PPH
  • Index Total Return Ticker

    MVPPHTR
  • NAV

    PPHNV
  • Intraday NAV (IIV)4

    PPHIV
  • Shares Outstanding

    4,288,138
  • Estimated Cash

    PPHEU
  • Total Cash

    PPHTC
  • CUSIP

    92189F692
  • ISIN

    US92189F6925
Source: Bloomberg

Fees and Expenses2

  • Management Fee

    0.35%
  • Other Expenses

    0.07%
  • Gross Expense Ratio

    0.42%
  • Fee Waivers and
    Expense Reimbursement

    -0.07%
  • Net Expense Ratio/TER2

    0.35%
2Expenses for PPH are capped contractually at 0.35% until February 1, 2022. Cap excludes acquired fund fees and expenses, interest expense, trading expenses, taxes and extraordinary expenses.

Investment Professionals

  • Portfolio Manager and Head of Equity ETFs
  • Oversees the Equity ETF Investment Management Team including development and management of index replication and optimization strategies
  • Joined VanEck in 2005
  • CFA charterholder; member of the CFA Society New York
  • BA, Mathematics and Economics, New York University
  • Portfolio Manager and Analyst for Equity ETFs
  • Joined VanEck in 2007
  • Prior to his current role, held a portfolio administration position at VanEck
  • Previously, Portfolio Analyst at Evaluation Associates
  • BS, Business Administration (concentration in Financial Analysis), State University of New York at Buffalo
  • Analyst for Equity ETFs
  • Joined VanEck in 2018
  • Prior to joining VanEck, ETF Basket Operations Analyst at JPMorgan
  • BS, Finance, Providence College
  • Analyst for Equity ETFs
  • Joined VanEck in 2019
  • Prior to VanEck, Intermediate Representative, Exchange Traded Funds at BNY Mellon.
  • BS, Accounting, Hunter College

Prices as of 07/23/21

NAV/
Market Price
Volume
30-Day Avg./
Last Trading Day
Daily Change
NAV/
Last Price
YTD Change
NAV/
Last Price
Premium/
Discount
Prem/Discount
Distribution Charts
NAV &
Prem/Discount
History
30-Day
Median
Bid Ask
Spread
NAV
Chart
PPH $74.40
$74.44
69,814
69,004
$0.61 / +0.83%
$0.62 / +0.84%
+13.44%
+13.35%
$0.04
0.05%
--

Premium/Discount History as of 07/23/21

Calendar Year 2020 3Q 2020 4Q 2020 1Q 2021 2Q 2021 Premium/Discount Charts NAV & Prem/Discount History
Days closed at a premium 124 29 41 32 37
PPH Days closed at NAV 17 8 1 6 5
Days closed at a discount 112 27 22 23 21


Performance History: Average Annual Total Returns* (%)

1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
12/20/11
PPH (NAV) 1.15 6.42 10.86 19.31 9.28 6.41 -- 9.94
PPH (Share Price) 1.26 6.40 10.92 19.38 9.34 6.45 -- 10.06
MVPPHTR (Index) 1.17 6.38 10.32 19.01 9.05 6.29 -- 9.85
Performance Differential (NAV - Index) -0.02 0.04 0.54 0.30 0.23 0.12 -- 0.09
1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
12/20/11
PPH (NAV) 1.15 6.42 10.86 19.31 9.28 6.41 -- 9.94
PPH (Share Price) 1.26 6.40 10.92 19.38 9.34 6.45 -- 10.06
MVPPHTR (Index) 1.17 6.38 10.32 19.01 9.05 6.29 -- 9.85
Performance Differential (NAV - Index) -0.02 0.04 0.54 0.30 0.23 0.12 -- 0.09

Top 10 Holdings (%) as of 06/30/21 Daily Holdings

Total Holdings: 25
Swipe
to view
full data
Holding Name
Ticker
Shares Market Value
(US$)
% of Net
Assets
MERCK & CO INC
MRK US
157,111
12,218,522 5.25
ASTRAZENECA PLC
AZN US
201,953
12,096,985 5.20
BRISTOL-MYERS SQUIBB CO
BMY US
177,867
11,885,073 5.11
ELI LILLY AND CO
LLY US
51,471
11,813,624 5.08
NOVO NORDISK A/S
NVO US
139,328
11,671,507 5.02
SANOFI
SNY US
220,396
11,606,053 4.99
JOHNSON & JOHNSON
JNJ US
70,249
11,572,820 4.97
NOVARTIS AG
NVS US
126,125
11,507,645 4.94
ABBVIE INC
ABBV US
102,040
11,493,786 4.94
PFIZER INC
PFE US
292,201
11,442,591 4.92
Top 10 Total (%) 50.42
These are not recommendations to buy or to sell any security. Securities and holdings may vary.

Country Weightings (%) as of 06/30/21

  • Country

    % of Net Assets
  • United States

    66.40
  • United Kingdom

    9.73
  • Denmark

    5.02
  • France

    4.99
  • Switzerland

    4.94
  • Japan

    4.44
  • Israel

    3.55
  • Ireland

    0.60
  • Other/Cash

    0.34

Sector Weightings (%) as of 06/30/21

  • Sector

    % of Net Assets
  • Health Care

    97.3
  • n/a

    2.4
  • Other/Cash

    0.3